Cart
sales@molnova.com
Ginsenoside Ra3
CAS No. 90985-77-6
Ginsenoside Ra3( —— )
Catalog No. M24950 CAS No. 90985-77-6
Ginsenoside Ra3 is a natural product isolated from Panax ginseng, has anti-cancer activity.?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 340 | In Stock |
|
| 10MG | 502 | In Stock |
|
| 25MG | 954 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGinsenoside Ra3
-
NoteResearch use only, not for human use.
-
Brief DescriptionGinsenoside Ra3 is a natural product isolated from Panax ginseng, has anti-cancer activity.?
-
DescriptionGinsenoside Ra3 is a natural product isolated from Panax ginseng, has anti-cancer activity.?
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number90985-77-6
-
Formula Weight1241.41
-
Molecular FormulaC59H100O27
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (40.28 mM)
-
SMILESCC12C3(C(C(O)CC1C4(C(C(C)(C(OC5C(C(C(O)C(CO)O5)O)OC6OC(C(O)C(O)C6O)CO)CC4)C)CC2)C)C(C(CC/C=C(C)/C)(C)OC7OC(C(O)C(O)C7O)COC8C(C(C(O)C(CO)O8)OC9C(C(C(O)CO9)O)O)O)CC3)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nag SA, et al. Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action. Front Pharmacol. 2012 Feb 28;3:25.
molnova catalog
related products
-
Grb2 SH2 Domain Liga...
Grb2 SH2 Domain Ligand
-
BV02
BV02 is an inhibitor of 14-3-3 protein-protein interactions and can be used in studies about the treatment of chronic myeloid leukemia. BV02 disrupts hematopoietic cells expressing the IM-resistant T315I mutation and the IM-sensitive wild-type Bcr-Abl.
-
HCV Core Protein (19...
PQDVKFP is a synthetic peptide, recognizing antigenic domains within the hepatitis C virus (HCV) core protein.
